Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015)

Introduction: Trypanosoma cruzi is the etiologic agent of American trypanosomiasis (Chagas disease), which is one of the important parasitic diseases worldwide. The number of infected people with T. cruzi diminished from 18 million in 1991 to 6 million in 2010, but it is still the most prevalent par...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rodriguez, J.B., Falcone, B.N., Szajnman, S.H.
Formato: JOUR
Materias:
antiparasitic agents
Chagas disease
diagnosis
drug discovery
drug treatment
Trypanosoma cruzi
benznidazole
boron derivative
cysteine proteinase
geranyltransferase
hydroxymethylglutaryl coenzyme A reductase
iron superoxide dismutase
methyltransferase
methyltransferase inhibitor
nifurtimox
phosphatidylinositol 3 kinase
sialidase
squalene monooxygenase
squalene synthase
squalene synthase inhibitor
sterol 14alpha demethylase
sterol 14alpha demethylase inhibitor
trypanothione
antitrypanosomal agent
diagnostic procedure
human
long term care
nonhuman
parasite identification
parasite serodiagnosis
patent
Review
unspecified side effect
animal
drug design
drug effects
drug resistance
isolation and purification
parasitemia
parasitology
Animals
Chagas Disease
Drug Design
Drug Resistance
Humans
Parasitemia
Patents as Topic
Trypanocidal Agents
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_13543776_v26_n9_p993_Rodriguez
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Ejemplares similares